{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:59:07Z","timestamp":1773500347741,"version":"3.50.1"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.neuropharm.2023.109569","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T20:43:19Z","timestamp":1683060199000},"page":"109569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders"],"prefix":"10.1016","volume":"235","author":[{"given":"Ferdinando","family":"Nicoletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Di Menna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Iacovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosamaria","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Zuena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Jeffrey","family":"Conn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max E.","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109569_bib1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1126\/scisignal.abd2494","article-title":"A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner","volume":"13","author":"Abd-Elrahman","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2023.109569_bib2","article-title":"Therapeutic anti-amyloid \u03b2 antibodies cause neuronal disturbances","author":"Adhikari","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2023.109569_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","article-title":"Serotonin model of schizophrenia: emerging role of glutamate mechanisms","volume":"31","author":"Aghajanian","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0092-8674(94)90204-6","article-title":"Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice","volume":"79","author":"Aiba","year":"1994","journal-title":"Cell"},{"issue":"6840","key":"10.1016\/j.neuropharm.2023.109569_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35082096","article-title":"Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer","volume":"411","author":"Ango","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib6","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/MCB.00201-08","article-title":"mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice","volume":"28","author":"Antion","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/npp.2016.2","article-title":"An mGlu5-positive allosteric modulator rescues the neuroplasticity deficits in a genetic model of NMDA receptor hypofunction in schizophrenia","volume":"41","author":"Balu","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109569_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuropharm.2016.06.004","article-title":"Metabotropic glutamate receptor, mGlu5, regulates hippocampal synaptic plasticity and is required for tetanisation-triggered changes in theta and gamma oscillations","volume":"115","author":"Bikbaev","year":"2017","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1021\/acsmedchemlett.7b00279","article-title":"Design and synthesis of mGlu2 NAMs with improved potency and CNS penetration based on a truncated picolinamide core","volume":"8","author":"Bollinger","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2023.109569_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuropharm.2016.06.003","article-title":"Metabotropic glutamate receptor, mGlu5, mediates enhancements of hippocampal long-term potentiation after environmental enrichment in young and old mice","volume":"115","author":"Buschler","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.28355","article-title":"A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1","volume":"36","author":"Bushart","year":"2021","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuroscience.2007.01.049","article-title":"Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo","volume":"146","author":"Cahusac","year":"2007","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","article-title":"Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap","volume":"9","author":"Calabresi","year":"2010","journal-title":"Lancet Neurol."},{"issue":"37","key":"10.1016\/j.neuropharm.2023.109569_bib14","doi-asserted-by":"crossref","first-page":"12909","DOI":"10.1523\/JNEUROSCI.0073-12.2012","article-title":"Transient receptor potential canonical channels regulate the induction of cerebellar long-term depression","volume":"32","author":"Chae","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109569_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2020.06.019","article-title":"A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis","volume":"249","author":"Chaumette","year":"2022","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","article-title":"The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease","volume":"16","author":"Chen","year":"2020","journal-title":"Purinergic Signal."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109569_bib17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0026-895X(24)12194-3","article-title":"L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors","volume":"61","author":"Chiechio","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109569_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm025570j","article-title":"3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity","volume":"46","author":"Cosford","year":"2003","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109569_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2018.07.010","article-title":"HDAC2-dependent antipsychotic-like effects of chronic treatment with the HDAC inhibitor SAHA in mice","volume":"388","author":"de la Fuente Revenga","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109569_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2017.10.026","article-title":"Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system","volume":"128","author":"Di Menna","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109569_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.biopsych.2021.02.970","article-title":"Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus","volume":"90","author":"Dogra","year":"2021","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109569_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173493","article-title":"Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders","volume":"221","author":"Dogra","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1096\/fj.10-163147","article-title":"A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors","volume":"25","author":"Doumazane","year":"2011","journal-title":"Faseb. J."},{"issue":"7864","key":"10.1016\/j.neuropharm.2023.109569_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-021-03641-w","article-title":"Structures of human mGlu2 and mGlu7 homo- and heterodimers","volume":"594","author":"Du","year":"2021","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.neuropharm.2023.109569_bib27","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"18","key":"10.1016\/j.neuropharm.2023.109569_bib28","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1021\/acs.jmedchem.5b01005","article-title":"Discovery of a selective and cns penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 with antidepressant and anxiolytic activity in rodents","volume":"58","author":"Engers","year":"2015","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopsych.2017.08.025","article-title":"Metabotropic glutamatergic receptor 5 and stress disorders: knowledge gained from receptor imaging studies","volume":"84","author":"Esterlis","year":"2018","journal-title":"Biol. Psychiatr."},{"issue":"18","key":"10.1016\/j.neuropharm.2023.109569_bib30","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1073\/pnas.172393799","article-title":"Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function","volume":"99","author":"Ferr\u00e9","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neulet.2011.06.024","article-title":"Inhibitors of diacylglycerol metabolism reduce time to the onset of glutamate release potentation by mGlu7 receptors","volume":"500","author":"Ferrero","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109569_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuropharm.2012.10.032","article-title":"Potentiation of mGlu7 receptor-mediated glutamate release at nerve terminals containing N and P\/Q type Ca2+ channels","volume":"67","author":"Ferrero","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109569_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuropharm.2015.07.025","article-title":"Cross-talk between metabotropic glutamate receptor 7 and beta adrenergic receptor signaling at cerebrocortical nerve terminals","volume":"101","author":"Ferrero","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib34","article-title":"A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes","volume":"6","author":"Fisher","year":"2021","journal-title":"J.C.I. insight"},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109569_bib35","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0028-3908(99)00123-9","article-title":"DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists","volume":"38","author":"Fitzjohn","year":"1999","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109569_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2023.109569_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(94)90857-5","article-title":"(2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices","volume":"659","author":"Genazzani","year":"1994","journal-title":"Brain Res."},{"issue":"7183","key":"10.1016\/j.neuropharm.2023.109569_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109569_bib39","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.npp.1300672","article-title":"Group II and III metabotropic glutamate receptors suppress excitatory synaptic transmission in the dorsolateral bed nucleus of the stria terminalis","volume":"30","author":"Grueter","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"33","key":"10.1016\/j.neuropharm.2023.109569_bib40","doi-asserted-by":"crossref","first-page":"17112","DOI":"10.1074\/jbc.M116.720664","article-title":"Oligomers of amyloid \u03b2 prevent physiological activation of the cellular prion protein-metabotropic glutamate receptor 5 complex by glutamate in alzheimer disease","volume":"291","author":"Haas","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.neuropharm.2023.109569_bib41","doi-asserted-by":"crossref","first-page":"28460","DOI":"10.1074\/jbc.M114.584342","article-title":"Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5)","volume":"289","author":"Haas","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.celrep.2017.06.023","article-title":"Silent allosteric modulation of mGlur5 maintains glutamate signaling while rescuing alzheimer's mouse phenotypes","volume":"20","author":"Haas","year":"2017","journal-title":"Cell Rep."},{"issue":"21","key":"10.1016\/j.neuropharm.2023.109569_bib43","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/cells11213352","article-title":"Role of mglu5 in persistent forms of hippocampal synaptic plasticity and the encoding of spatial experience","volume":"11","author":"Hagena","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2023.109569_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1756-6606-7-40","article-title":"Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease","volume":"7","author":"Hamilton","year":"2014","journal-title":"Mol. Brain"},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib45","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic pharmacological mGlur5 inhibition prevents cognitive impairment and reduces pathogenesis in an alzheimer disease mouse model","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Rep."},{"issue":"13","key":"10.1016\/j.neuropharm.2023.109569_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132004","article-title":"mGlur5 is substitutable for mGlur1 in cerebellar purkinje cells for motor coordination, developmental synapse elimination, and motor learning","volume":"11","author":"Harbers","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0269881108089818","article-title":"The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia","volume":"22","author":"Harrison","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00109-015-1298-7","article-title":"TRPC3-dependent synaptic transmission in central mammalian neurons","volume":"93","author":"Hartmann","year":"2015","journal-title":"J. Mol. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2023.109569_bib49","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/nn764","article-title":"GABA(B) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses","volume":"4","author":"Hirono","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109569_bib50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.08.010","article-title":"Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease","volume":"60","author":"Horgusluoglu-Moloch","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1471-4159.2005.03527.x","article-title":"Sustained activation of metabotropic glutamate receptor 5 and protein tyrosine phosphatases mediate the expression of (S)-3,5-dihydroxyphenylglycine-induced long-term depression in the hippocampal CA1 region","volume":"96","author":"Huang","year":"2006","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib52","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1523\/JNEUROSCI.4247-06.2007","article-title":"Repeated cocaine administration impairs group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex","volume":"27","author":"Huang","year":"2007","journal-title":"J. Neurosci."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2023.109569_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2016.10.018","article-title":"Type-7 metabotropic glutamate receptors negatively regulate \u03b11-adrenergic receptor signalling","volume":"113","author":"Iacovelli","year":"2017","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib54","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1073\/pnas.1511513113","article-title":"Et al. Territories of heterologous inputs onto Purkinje cell dendrites are segregated by mGluR1-dependent parallel fiber synapse elimination","volume":"113","author":"Ichikawa","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13023-021-01951-w","article-title":"A large consanguineous family with a homozygous metabotropic glutamate receptor 7 (mGlu7) variant and developmental epileptic encephalopathy: effect on protein structure and ligand affinity","volume":"16","author":"Jdila","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"4\u20135","key":"10.1016\/j.neuropharm.2023.109569_bib56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/lm.5.4.331","article-title":"Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5","volume":"5","author":"Jia","year":"1998","journal-title":"Learn. Mem."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib57","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/mp.2016.129","article-title":"mGluR2\/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions","volume":"22","author":"Jin","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109569_bib58","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41380-017-0015-z","article-title":"Metabotropic glutamate receptor subtype 3 gates acute stress-induced dysregulation of amygdalo-cortical function","volume":"24","author":"Joffe","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109569_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2018.10.013","article-title":"Mechanisms underlying prelimbic prefrontal cortex mGlu3\/mGlu5-dependent plasticity and reversal learning deficits following acute stress","volume":"144","author":"Joffe","year":"2019","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2023.109569_bib60","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41386-021-01041-2","article-title":"Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors","volume":"46","author":"Joffe","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2011.09.007","article-title":"Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata","volume":"504","author":"Johnson","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"45","key":"10.1016\/j.neuropharm.2023.109569_bib62","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1523\/JNEUROSCI.3660-05.2005","article-title":"Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice","volume":"25","author":"Kachroo","year":"2005","journal-title":"J. Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2023.109569_bib63","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1113\/jphysiol.2007.141010","article-title":"Postsynaptic GABAB receptor signalling enhances LTD in mouse cerebellar Purkinje cells","volume":"585","author":"Kamikubo","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109569_bib64","doi-asserted-by":"crossref","first-page":"416","DOI":"10.12688\/f1000research.10485.1","article-title":"Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease","volume":"6","author":"Kano","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0896-6273(01)80047-7","article-title":"Persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking mGluR1","volume":"18","author":"Kano","year":"1997","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109569_bib66","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/mp.2012.59","article-title":"Prefrontal synaptic markers of cocaine addiction-like behavior in rats","volume":"18","author":"Kasanetz","year":"2013","journal-title":"Mol. Psychiatr."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/brainsci9080183","article-title":"Metabotropic glutamate receptor subtype 5 in alcohol-induced negative affect","volume":"9","author":"Kasten","year":"2019","journal-title":"Brain Sci."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib68","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","article-title":"Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2\/3 receptor agonist pomaglumetad methionil in schizophrenia","volume":"78","author":"Kinon","year":"2015","journal-title":"Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.conb.2005.05.011","article-title":"Towards a view of functioning dimeric metabotropic receptors","volume":"15","author":"Kubo","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib70","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1152\/jn.00249.2007","article-title":"Aging effects on the limits and stability of long-term synaptic potentiation and depression in rat hippocampal area CA1","volume":"98","author":"Kumar","year":"2007","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/00207454.2013.841685","article-title":"Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients","volume":"126","author":"Kumar","year":"2016","journal-title":"Int. J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109569_bib72","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1124\/mol.112.084582","article-title":"Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice","volume":"83","author":"Kurita","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109569_bib73","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuron.2007.11.024","article-title":"Long-term potentiation selectively expressed by NMDA receptors at hippocampal mossy fiber synapses","volume":"57","author":"Kwon","year":"2008","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib75","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/mp.2015.43","article-title":"Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory","volume":"20","author":"Li","year":"2015","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41398-020-0763-4","article-title":"Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia","volume":"10","author":"Liang","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"23","key":"10.1016\/j.neuropharm.2023.109569_bib77","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.3390\/cells11233916","article-title":"Targeting mGlu1 receptors in the treatment of motor and cognitive dysfunctions in mice modeling type 1 spinocerebellar ataxia","volume":"11","author":"Liberatore","year":"2022","journal-title":"Cells"},{"issue":"7864","key":"10.1016\/j.neuropharm.2023.109569_bib78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03495-2","article-title":"Structures of Gi-bound metabotropic glutamate receptors mGlu2 and mGlu4","volume":"594","author":"Lin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109569_bib79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2012.04.006","article-title":"Selective activation of either mGlu2 or mGlu3 receptors can induce LTD in the amygdala","volume":"66","author":"Lucas","year":"2013","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109569_bib80","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/1570159X13666150514232745","article-title":"The role of metabotropic glutamate receptor genes in schizophrenia","volume":"14","author":"Maj","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109569_bib81","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1523\/JNEUROSCI.4360-04.2005","article-title":"The scaffold protein Homer1b\/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons","volume":"25","author":"Mao","year":"2005","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109569_bib82","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/acn3.51003","article-title":"Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy","volume":"7","author":"Marafi","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(24)35262-0","article-title":"Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex","volume":"292","author":"Marek","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1460-9568.2007.05660.x","article-title":"mGluR7 inhibits glutamate release through a PKC-independent decrease in the activity of P\/Q-type Ca2+ channels and by diminishing cAMP in hippocampal nerve terminals","volume":"26","author":"Mart\u00edn","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib85","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2008.04.011","article-title":"The inhibition of release by mGlu7 receptors is independent of the Ca2+ channel type but associated to GABAB and adenosine A1 receptors","volume":"55","author":"Mart\u00edn","year":"2008","journal-title":"Neuropharmacology"},{"issue":"23","key":"10.1016\/j.neuropharm.2023.109569_bib86","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1074\/jbc.M109.080838","article-title":"The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals","volume":"285","author":"Mart\u00edn","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2023.109569_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108801","article-title":"The evidence for and consequences of metabotropic glutamate receptor heterodimerization","volume":"199","author":"McCullock","year":"2021","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gep.2016.10.001","article-title":"Developmental expression of mGlu2 and mGlu3 in the mouse brain","volume":"22","author":"McOmish","year":"2016","journal-title":"Gene Expr. Patterns"},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib89","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41589-022-01050-2","article-title":"Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain","volume":"18","author":"Meng","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"16","key":"10.1016\/j.neuropharm.2023.109569_bib90","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1074\/jbc.M109044200","article-title":"The inhibition of glutamate release by metabotropic glutamate receptor 7 affects both [Ca2+]c and cAMP: evidence for a strong reduction of Ca2+ entry in single nerve terminals","volume":"277","author":"Mill\u00e1n","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"53","key":"10.1016\/j.neuropharm.2023.109569_bib91","doi-asserted-by":"crossref","first-page":"44301","DOI":"10.1074\/jbc.M112.413161","article-title":"Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A\u00b7mGlu2) receptor heteromerization and its psychoactive behavioral function","volume":"287","author":"Moreno","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib92","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41380-018-0069-6","article-title":"5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi\/o signaling","volume":"24","author":"Murat","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"12","key":"10.1016\/j.neuropharm.2023.109569_bib93","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1073\/pnas.1216100110","article-title":"L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors","volume":"110","author":"Nasca","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109569_bib94","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1523\/JNEUROSCI.06-07-01905.1986","article-title":"The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells","volume":"6","author":"Nicoletti","year":"1986","journal-title":"J. Neurosci."},{"issue":"7\u20138","key":"10.1016\/j.neuropharm.2023.109569_bib95","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: from the workbench to the bedside","volume":"60","author":"Nicoletti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109569_bib96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2015.07.047","article-title":"Association study of GRM7 polymorphisms and schizophrenia in the Chinese Han population","volume":"604","author":"Niu","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109569_bib97","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1756-6606-6-48","article-title":"Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1","volume":"6","author":"Notartomaso","year":"2013","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2023.109569_bib98","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917697009","article-title":"Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain","volume":"13","author":"Notartomaso","year":"2017","journal-title":"Mol. Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31369-7","article-title":"mGlu1 receptors monopolize the synaptic control of cerebellar purkinje cells by epigenetically down-regulating mGlu5 receptors","volume":"8","author":"Notartomaso","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib100","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1038\/s41598-018-22768-x","article-title":"Physiological activation of mGlu5 receptors supports the ion channel function of NMDA receptors in hippocampal LTD induction in vivo","volume":"8","author":"O'Riordan","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib101","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1523\/JNEUROSCI.22-09-03434.2002","article-title":"Long-term depression induced by postsynaptic group II metabotropic glutamate receptors linked to phospholipase C and intracellular calcium rises in rat prefrontal cortex","volume":"22","author":"Otani","year":"2002","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.neuropharm.2023.109569_bib102","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1111\/bph.13180","article-title":"Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice","volume":"172","author":"Pagnussat","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"11\u201312","key":"10.1016\/j.neuropharm.2023.109569_bib103","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0028-3908(97)00181-0","article-title":"The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus","volume":"36","author":"Palmer","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109569_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuropharm.2012.12.003","article-title":"Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic target","volume":"82","author":"Parmentier-Batteur","year":"2014","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib105","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuron.2005.02.011","article-title":"mGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition","volume":"46","author":"Pelkey","year":"2005","journal-title":"Neuron"},{"issue":"7631","key":"10.1016\/j.neuropharm.2023.109569_bib107","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature20566","article-title":"Organization and functions of mGlu and GABAB receptor complexes","volume":"540","author":"Pin","year":"2016","journal-title":"Nature"},{"issue":"Pt 22","key":"10.1016\/j.neuropharm.2023.109569_bib108","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1113\/jphysiol.2009.179978","article-title":"G-protein-coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors","volume":"587","author":"Pin","year":"2009","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib109","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1096\/fasebj.9.2.7781920","article-title":"Protein kinases that phosphorylate activated G protein-coupled receptors","volume":"9","author":"Premont","year":"1995","journal-title":"Faseb. J."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.coph.2009.10.009","article-title":"Functional crosstalk between GPCRs: with or without oligomerization","volume":"10","author":"Prezeau","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib111","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12035-011-8214-0","article-title":"Serotonin and prefrontal cortex function: neurons, networks, and circuits","volume":"44","author":"Puig","year":"2011","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib112","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.parkreldis.2014.05.003","article-title":"Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias","volume":"20","author":"Rascol","year":"2014","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109569_bib113","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuron.2018.05.018","article-title":"Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert","volume":"98","author":"Reiner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109569_bib114","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2215148","article-title":"Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke","author":"Reish","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.neuropharm.2023.109569_bib115","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/emboj.2009.177","article-title":"Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration","volume":"28","author":"Rives","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2023.109569_bib116","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211022197","article-title":"Baclofen therapeutics, toxicity, and withdrawal: a narrative review","volume":"9","author":"Romito","year":"2021","journal-title":"SAGE Open Med"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib117","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1523\/JNEUROSCI.5019-07.2008","article-title":"Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation","volume":"28","author":"Ronesi","year":"2008","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109569_bib118","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.biopsych.2012.09.012","article-title":"Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in vivo activity","volume":"73","author":"Rook","year":"2013","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib119","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neuron.2015.03.063","article-title":"Biased mGlu5-positive allosteric modulators provide in vivo efficacy without potentiating mGlu5 modulation of NMDAR currents","volume":"86","author":"Rook","year":"2015","journal-title":"Neuron"},{"issue":"45","key":"10.1016\/j.neuropharm.2023.109569_bib120","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1523\/JNEUROSCI.1519-16.2016","article-title":"Activation of group II metabotropic glutamate receptors promotes LTP induction at Schaffer collateral-CA1 pyramidal cell synapses by priming NMDA receptors","volume":"36","author":"Rosenberg","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109569_bib121","article-title":"Response to: multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for Stroke","author":"Sabbagh","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib122","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/tpj.2015.90","article-title":"The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis","volume":"17","author":"Sacchetti","year":"2017","journal-title":"Pharmacogenomics J."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib123","doi-asserted-by":"crossref","first-page":"e1196","DOI":"10.1038\/tp.2017.172","article-title":"Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk","volume":"7","author":"Saini","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib124","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbrc.2016.09.062","article-title":"Cellular prion protein as a receptor for amyloid-\u03b2 oligomers in Alzheimer's disease","volume":"483","author":"Salazar","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109569_bib125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13195-022-01141-1","article-title":"A\u03b242 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extracts","volume":"14","author":"Sandberg","year":"2022","journal-title":"Alzheimer's Res. Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib126","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jnc.13291","article-title":"Adenosine A\u2082A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation","volume":"135","author":"Sarantis","year":"2015","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.neuropharm.2023.109569_bib127","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0028-3908(96)00121-9","article-title":"The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors","volume":"35","author":"Schoepp","year":"1996","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109569_bib128","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3908(99)00092-1","article-title":"Pharmacological agents acting at subtypes of metabotropic glutamate receptors","volume":"38","author":"Schoepp","year":"1999","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib129","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI126361","article-title":"D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease","volume":"130","author":"Sebastianutto","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"7867","key":"10.1016\/j.neuropharm.2023.109569_bib130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03680-3","article-title":"G-protein activation by a metabotropic glutamate receptor","volume":"595","author":"Seven","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: from simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"22","key":"10.1016\/j.neuropharm.2023.109569_bib132","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s00018-019-03275-2","article-title":"G-protein \u03b2\u03b3 subunits as multi-functional scaffolds and transducers in G-protein-coupled receptor signaling","volume":"76","author":"Smrcka","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib133","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1523\/JNEUROSCI.2108-20.2021","article-title":"Pathogenic GRM7 mutations associated with neurodevelopmental disorders impair axon outgrowth and presynaptic terminal development","volume":"41","author":"Song","year":"2021","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.neuropharm.2023.109569_bib134","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/mds.25561","article-title":"AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study","volume":"28","author":"Stocchi","year":"2013","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109569_bib135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1358\/dot.2022.58.10.3422314","article-title":"Aducanumab for the treatment of Alzheimer's disease","volume":"58","author":"Tagliapietra","year":"2022","journal-title":"Drugs Today"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib136","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(01)00305-0","article-title":"Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites","volume":"106","author":"Tamaru","year":"2001","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109569_bib137","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczy\u0144ska","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib138","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2005.03455.x","article-title":"Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects","volume":"95","author":"Tebano","year":"2005","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib139","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","article-title":"Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors","volume":"25","author":"Temido-Ferreira","year":"2020","journal-title":"Mol. Psychiatr."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cells7080090","article-title":"GABAB receptors augment TRPC3-mediated slow excitatory postsynaptic current to regulate cerebellar Purkinje neuron response to type-1 metabotropic glutamate receptor activation","volume":"7","author":"Tian","year":"2018","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib141","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/mds.26659","article-title":"A phase 2A trial of the novel mGluR5-negative allosteric modulator dipraglurant for levodopa-induced dyskinesia in Parkinson's disease","volume":"31","author":"Tison","year":"2016","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109569_bib142","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/mds.26585","article-title":"Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: two randomized phase 2 studies","volume":"31","author":"Trenkwalder","year":"2016","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109569_bib143","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.biopsych.2010.09.004","article-title":"Metabotropic glutamate receptor 5\/Homer interactions underlie stress effects on fear","volume":"68","author":"Tronson","year":"2010","journal-title":"Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib144","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(00)80810-7","article-title":"Coupling of mGluR\/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins","volume":"23","author":"Tu","year":"1999","journal-title":"Neuron"},{"issue":"47","key":"10.1016\/j.neuropharm.2023.109569_bib145","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1523\/JNEUROSCI.0063-22.2022","article-title":"Modulation of hippocampal network oscillation by PICK1-dependent cell surface expression of mGlu3 receptors","volume":"42","author":"Tuduri","year":"2022","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109569_bib146","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a\u03b2 oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109569_bib147","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnmol.2018.00324","article-title":"Presynaptic mGlu1 receptors control GABAB receptors in an antagonist-like manner in mouse cortical GABAergic and glutamatergic nerve endings","volume":"11","author":"Vergassola","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109569_bib148","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"Beta-arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib149","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1523\/JNEUROSCI.4333-12.2013","article-title":"Homer1 mediates acute stress-induced cognitive deficits in the dorsal hippocampus","volume":"33","author":"Wagner","year":"2013","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib150","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1073\/pnas.1416196112","article-title":"Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction","volume":"112","author":"Walker","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109569_bib151","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3565(25)38417-X","article-title":"Pharmacological differentiation of metabotropic glutamate receptors coupled to potentiation of cyclic adenosine monophosphate responses and phosphoinositide hydrolysis","volume":"266","author":"Winder","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109569_bib152","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.tcb.2020.06.002","article-title":"Conformational basis of G protein-coupled receptor signaling versatility","volume":"30","author":"Wingler","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109569_bib153","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/acsptsci.9b00017","article-title":"mGlu5 positive allosteric modulators facilitate long-term potentiation via disinhibition mediated by mGlu5-endocannabinoid signaling","volume":"2","author":"Xiang","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109569_bib154","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0896-6273(00)80588-7","article-title":"Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins","volume":"21","author":"Xiao","year":"1998","journal-title":"Neuron"},{"issue":"50","key":"10.1016\/j.neuropharm.2023.109569_bib155","doi-asserted-by":"crossref","first-page":"16762","DOI":"10.1523\/JNEUROSCI.2869-13.2014","article-title":"Hippocampal metaplasticity is required for the formation of temporal associative memories","volume":"34","author":"Xu","year":"2014","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:23:46Z","timestamp":1758439426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823001594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":155,"alternative-id":["S0028390823001594"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109569","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109569"}}